1-4 of 4
Zeba Aziz, MD MBBS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study

Raymond SM Wong, MRCP,FRCP, Russell K Brynes, Attilio Orazi, Zeba Aziz, MD MBBS, Anait L. Melikyan, MD PhD, Abdulgabar Salama, Ozlem Ocak Arikan, Joan Maier, Tahir Shamsi, Professor of Haematology (FRCPath)
Journal: Blood
Blood (2017) 130 (Supplement 1): 3628.
https://doi.org/10.1182/blood.V130.Suppl_1.3628.3628
Published: 2017
Journal Articles

Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase

Zafar Iqbal, MPhil PhDPost-doc., Afia Muhammad Akram, Tanveer Akhtar, PhD, Aamer Aleem, MBBS FRCP, Muhammad Farooq Sabar, PhD, Zeba Aziz, MD MBBS, Nadia Sajid, Mahmood Rasool, PhD, Muhammad Asif, Mehmood Husssain Qazi, PhD, Saleh Oraibi, PhD, Ammara T Gill, MBBS ABIM, Khalid Al Jamaan, MDFRCPC, Mudassar Iqbal, MDMS, Ahmad Mukhtar Khalid
Journal: Blood
Blood (2016) 128 (22): 3089.
https://doi.org/10.1182/blood.V128.22.3089.3089
Published: 2016
Journal Articles

High Frequencies of Compound BCR-ABL Mutations and Their Association with Imatinib Resistant, Disease Progression and Late Chronic Phase Disease in Pakistani Chronic Myeloid Leukemia Patients Necessitate the Inclusion of Molecular Testing in Routine Clinical Settings

Zafar Iqbal, PhD, Afia Muhammad Akram, Tanveer Akhtar, PhD, Muhammad Khalid, MPhil PhD, Zeba Aziz, MD MBBS, Aamer Aleem, MBBS FRCP, Ammara T Gill, MBBS ABIM, Ahmad M Khalid, PhD, Abdullah Alanazi, MBBS, Ijaz H Shah, MD, Muhammad Khalid, MBBS, MPhil, Muhammad Farooq Sabar, PhD, Mudassar Iqbal
Journal: Blood
Blood (2015) 126 (23): 5167.
https://doi.org/10.1182/blood.V126.23.5167.5167
Published: 2015
Journal Articles

Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol

Zafar Iqbal, MPhil PhDPost-Doctorate, Tanveer Akhtar, PhDPost-Doctorate, Afia M Akram, Muhammad Khalid, MS PhD, Ijaz Husssain Shah, MBBS FCPS, Aamir Aleem, MBBS MRCP FRCPath, Muhammad Khalid, MBBS FCPS, Javed Iqbal, MBBS FCPS, Zeba Aziz, MD MBBS, Muhammad Absar, MSc, Jamil Amjad Hashmi, PhDPost-Doctorate, Mehmood Husssain Qazi, PhD, Ahmad Mukhtar Khalid, MSc, PhD, Muhammad Farooq Sabar, PhD, Sajjad Karim, PhD, Mahmood Rasool, MSc PhD, Aamir Mahmood, PhD, Ammara Tariq Gill, MD, Giuseppe Saglio, MD, Mudassar Iqbal, MD
Journal: Blood
Blood (2014) 124 (21): 1810.
https://doi.org/10.1182/blood.V124.21.1810.1810
Published: 2014